VXSPR helps pharmaceutical value teams measure, visualize, and communicate the financial and clinical-economic ROI of therapy and service contracts to payers, hospitals, PBMs, employers, and provider groups.
187%
Avg portfolio ROI
$48M
Net savings tracked
12+
Active contracts
Portfolio ROI
187.4%
Net savings
$48.2M
PMPM
$3.74
Avoided hosp.
1,284
Contracts
12
Platform
Translate clinical outcomes into financial impact across the portfolio.
Real-time status on every value-based agreement and rebate threshold.
Executive-grade ROI deliverables for payers, hospitals, and PBMs.
Predictive cohorts surface high-cost and high-discontinuation risk early.
Who it's for
Equip your contracting, HEOR, and account leadership with one shared system of record for therapeutic ROI.
Defend pricing with hard outcomes data and rebate-aware modeling.
Walk into renewals with client-ready ROI narratives, not spreadsheets.
Stand up a rigorous ROI layer on top of claims and outcomes warehouses.
Trust & compliance
VXSPR is an analytics and reporting layer. In production it deploys inside the client's secure environment with role-based access, audit logs, and no movement of PHI.
Deploys in client environment
Connect to client-owned warehouses; PHI never leaves their VPC.
Role-based access & audit logs
Granular permissions for value, account, and HEOR roles.
Analytics layer, not a medical device
Financial and operational ROI only — never clinical decisioning.
Demo environment. All data shown is synthetic. VXSPR is intended for financial and operational ROI analytics only — not a medical device, diagnostic tool, or substitute for clinical judgment.
Ready to explore?
The interactive demo is loaded with synthetic contracts, outcomes, and risk cohorts.